Antiplatelet therapy in code STEMI: who, when and where?

9 More presentations in this session

Anticoagulant switch in non-ST elevation acute myocardial infarction: prevalence and impact in in-hospital morbidity and mortality

Doctor B. Picarra (Evora, PT)

Abstract

Dual antiplatelet therapy in Russian patients beyond 12 months after myocardial infarction (EPICOR-RUS study)

Doctor Y. Khomitskaya (Moscow, RU)

Abstract Slides

Prevalence and appropriateness of antiplatelet therapy in acute coronary syndromes: a single centre real world experience.

Doctor B. Musumeci (Rome, IT)

Abstract

Use of new antiplatelet drugs in elderly patients with acute coronary syndrome in the real world.

Doctor L. Madrona Jimenez (Seville, ES)

Clinical events after percutaneous coronary intervention depending on dual antiplatelet therapy cessation

Doctor M. Marina Breysse (Madrid, ES)